Nu-Med Plus (NUMD) Convertible Debt (2013 - 2017)
Nu-Med Plus (NUMD) reported Convertible Debt of $130100.0 for Q3 2017, little changed on a YoY basis from $130100.0 in Q3 2016, and little changed sequentially from $130100.0 in Q2 2017.
Nu-Med Plus (NUMD) Convertible Debt (2013 - 2017) Analysis & Trends
Nu-Med Plus (NUMD) has 5 years of Convertible Debt data on file, last reported at $130100.0 in Q3 2017.
- For the quarter ending Q3 2017, Convertible Debt changed 0.0% year-over-year to $130100.0; the trailing twelve-month figure through Sep 2017 stood at $130100.0 (changed 0.0% YoY), and the FY2016 full-year result was $130100.0, changed 0.0% from the prior year.
- Convertible Debt steadied at $130100.0 in Q3 2017, from $130100.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $130100.0 in Q4 2013 to a low of $130100.0 in Q4 2013.
- A 5-year average of $130100.0 and a median of $130100.0 in 2013 frame the typical range for Convertible Debt.
- Peak annual rise in Convertible Debt reached 0.0% in 2015, while the deepest fall reached 0.0% in 2015.
- Tracing NUMD's Convertible Debt over 5 years: stood at $130100.0 in 2013, then changed by 0.0% to $130100.0 in 2014, then changed by 0.0% to $130100.0 in 2015, then changed by 0.0% to $130100.0 in 2016, then changed by 0.0% to $130100.0 in 2017.
- Business Quant data shows NUMD's Convertible Debt at $130100.0 in Q3 2017, $130100.0 in Q2 2017, and $130100.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 130,100.00 |
| Jun 30, 2017 | 130,100.00 |
| Mar 31, 2017 | 130,100.00 |
| Dec 31, 2016 | 130,100.00 |
| Sep 30, 2016 | 130,100.00 |
| Jun 30, 2016 | 130,100.00 |
| Mar 31, 2016 | 130,100.00 |
| Dec 31, 2015 | 130,100.00 |
| Sep 30, 2015 | 130,100.00 |
| Jun 30, 2015 | 130,100.00 |
| Mar 31, 2015 | 130,100.00 |
| Sep 30, 2014 | 130,100.00 |
| Jun 30, 2014 | 130,100.00 |
| Mar 31, 2014 | 130,100.00 |
| Dec 31, 2013 | 130,100.00 |